Sofinnova is a life sciences venture capital firm headquartered in Menlo Park, California, with additional offices in Boston and New York. The firm specializes in biotechnology and biopharmaceutical investments, deploying both private equity and public equity strategies. Sofinnova's investment team comprises primarily doctors and doctorate holders who bring deep scientific expertise to company building, drug development, regulatory navigation, and taking companies through IPO. Since inception, Sofinnova has funded 120 companies, supported 55 IPOs, and seen 36 FDA drug approvals across its portfolio. The firm operates both private equity funds focused on early-stage biotech company formation and public equity funds that invest in later-stage life sciences companies. Recent portfolio successes include Vera (FDA approval for TRUTAKNA™) and Star Therapeutics (acquired by Incyte).

Profile auto-generated from public sources — details unverified.